PRAME expression and clinical outcome of breast cancer

The tumour antigen PReferentially expressed Antigen of MElanoma (PRAME) is expressed in a variety of malignancies, including breast cancer. We have analysed PRAME gene expression in relation to clinical outcome for 295 primary breast cancer patients. Kaplan–Meier survival curves show a correlation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Epping, M T, Hart, A A M, Glas, A M, Krijgsman, O, Bernards, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527791/
https://www.ncbi.nlm.nih.gov/pubmed/18648365
http://dx.doi.org/10.1038/sj.bjc.6604494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527791/
https://www.ncbi.nlm.nih.gov/pubmed/18648365
http://dx.doi.org/10.1038/sj.bjc.6604494

Ejemplares similares